We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
29 Aug 2020 - 02 Sep 2020
Virtual Venue

Medical Management of Brain AVMs Superior to Interventions

By HospiMedica International staff writers
Posted on 02 Jul 2020
Print article
Image: Radiological appearance of an unruptured AVM (Photo courtesy of ThinkStock)
Image: Radiological appearance of an unruptured AVM (Photo courtesy of ThinkStock)
A new study shows that interventional treatment for unruptured arteriovenous malformations (AVMs) in the brain could be more dangerous than the disease itself.

Researchers at Columbia University (CU; New York, NY, USA), the Icahn School of Medicine at Mount Sinai (New York, NY, USA), and other institutions in nine countries conducted a randomized study at 39 clinical centers that included 226 patients (average age 44 years) diagnosed with an unruptured brain AVM. Patients were randomly assigned to medical management alone, or with an interventional therapy that included neurosurgery, embolization, or stereotactic radiotherapy. The primary outcome was time to death or symptomatic stroke as confirmed by imaging.

The results revealed that during a mean follow-up of 50.4 months, the primary outcome was lower with medical management alone (3.39 per 100 patient-years) than medical management with interventional therapy (12.32 per 100 patient-years); two patients in the medical management group and four in the interventional therapy group died during follow-up. Adverse events were observed less often in patients allocated to medical management compared with interventional therapy (58.97 versus 78.73 per 100 patient-years). The study was published in the July 2020 issue of The Lancet Neurology.

“The study showed that medical management alone remained superior to interventional therapy for the prevention of death or symptomatic stroke in patients with an unruptured brain AVM, “concluded lead author Professor JayMohr, MD, of CU Irving Medical Center. “The data concerning the disparity in outcomes should affect standard specialist practice and the information presented to patients. The even longer-term risks and differences between the two therapeutic approaches remains uncertain.”

A brain AVM is a tangle of abnormal blood vessels connecting arteries and veins in the brain, directing blood away from normal brain tissue. These abnormal and weak blood vessels dilate over time, and may burst eventually from the high pressure of blood flow from the arteries. Symptoms vary, with up to 50% suffering an intracranial hemorrhage, and 25% having focal or generalized seizures. AVMs are usually congenital, and occur in less than one percent of the general population.

Related Links:
Columbia University
Icahn School of Medicine at Mount Sinai



Print article

Channels

Business

view channel
Illustration

Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio

Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.